Contact us

A division of Aptar Pharma

We are on a mission to enhance patient experiences with their treatment, leveraging our proven expertise and our robust technology platforms to deliver differentiating solutions that support every unique patient.

Aptar Digital Health is a division of Aptar Pharma

A global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions and services.

Discover Aptar Pharma

Aptar Digital Health consolidates the legacy of 3 innovative companies across the fields of integrated digital health solutions, patient support programs, and connected devices. Our unmatched experience and expertise is demonstrated through a portfolio of regulated products that span multiple therapeutic areas . Driven by innovation and powered by patient, provider and partner needs, we offer fully integrated solutions, app platforms, and extensions (add-ons) that complement Aptar Pharma’s broad range of drug delivery solutions.

Our global footprint includes teams across the US, Germany, France, UK, and Japan, and passionate experts in all the key areas driving our mission to enhance the patient experience. From medical professionals to UX designers, software and hardware engineers, as well as quality and regulatory experts, we’re dedicated to delivering the best cutting-edge digital solutions on the market.

Aptar Pharma initiated the Digital Health Division of the company with an extensive portfolio of connected devices in diverse therapeutic areas

Aptar Pharma is a specialist in Injectables and Dermatology, as well as Eye Care and Nasal drug delivery. We’re driven by a commitment to being the go-to partner for global digital health innovations, offering all-in-one solutions and services, leveraging digital technology to solve pain points in care delivery and patient journeys.

In 2020, Aptar Pharma acquired Cohero Health

A company with a background in innovative digital health tools, and technologies that transform utilization management, as part of our mission to improve respiratory care for asthma and chronic obstructive pulmonary disorder, reduce avoidable costs, and optimize medication utilization.

In 2021, Aptar Pharma acquired Voluntis

A leader in digital therapeutics which use evidence-based clinical algorithms to deliver personalized and real-time recommendations to patients for improved symptom management, dosing, and adherence. Voluntis has been historically focused on oncology and chronic diseases such as diabetes or coagulation.

Today, Aptar Digital Health leverages an unmatched expertise of over 20 years

We are a global partner in the digital health industry and strategic brand partnerships to enhance the treatment experience for all patients. Our long-standing track record of collaborations with the pharmaceutical industry offers an industry-leading portfolio of regulated, digital health platforms and services across multiple therapeutic areas and geographies. Driven by our conviction that enhancing patient experiences is key to delivering more positive outcomes, we strive to be the go-to partner for pharma companies and providers to build solutions that empower patients to be more engaged in their treatment and help improve lives all around the world.

Back to top
Follow us: subscribe